Company · CIK 1395064
TAKEDA PHARMACEUTICAL CO LTD
| CIK | 1395064 (SEC EDGAR) |
|---|---|
| Industry (SIC) | 2834 — Pharmaceutical Preparations |
| Business address | Japan |
| Listed | TAK (NYSE), TKPHF (OTC) |
| First annual or quarterly report | 2019-06-27 |
Offerings
0 registrationsNo offering chain starts here after 2002-11-04: the company's filings belong to registrations filed earlier, or to drafts and notices only.
Filings
8| Filed | Filing | Registration | Accession |
|---|---|---|---|
| 2025-06-26 | 424B5Shelf takedown | 333-288301 | 0001395064-25-000101 |
| 2024-06-27 | 424B5Shelf takedown | 333-280469 | 0001395064-24-000091 |
| 2020-06-25 | 424B5Shelf takedown | 333-239409 | 0001193125-20-178205 |
| 2020-06-25 | 424B5Shelf takedown | 333-239409 | 0001193125-20-178198 |
| 2020-03-02 | EFFECTDeclared effective | 333-233160 | 9999999995-20-000449 |
| 2019-11-14 | EFFECTDeclared effective | 333-233160 | 9999999995-19-002568 |
| 2018-09-11 | DRSDraft made public | 377-02261 | 0000950123-18-009384 |
| 2010-05-10 | EFFECTDeclared effective | 333-166263 | 9999999995-10-001444 |